Seth Arum

1.2k total citations · 1 hit paper
24 papers, 496 citations indexed

About

Seth Arum is a scholar working on Molecular Biology, Epidemiology and Nephrology. According to data from OpenAlex, Seth Arum has authored 24 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Epidemiology and 5 papers in Nephrology. Recurrent topics in Seth Arum's work include Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Neuroendocrine Tumor Research Advances (5 papers) and Parathyroid Disorders and Treatments (5 papers). Seth Arum is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Neuroendocrine Tumor Research Advances (5 papers) and Parathyroid Disorders and Treatments (5 papers). Seth Arum collaborates with scholars based in United States, Italy and France. Seth Arum's co-authors include Cecilia M. Smith, Christopher R. Gilbert, Julian D. Gillmore, Violaine Planté‐Bordeneuve, David Adams, Joshua R. Vest, John L. Berk, Prajakta Badri, Chongshu Chen and Ivailo Tournev and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Seth Arum

24 papers receiving 485 citations

Hit Papers

Efficacy and safety of vutrisiran for patients with hered... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
    2022 218 citations David Adams, Ivailo Tournev et al. Amyloid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth Arum United States 8 266 85 75 64 60 24 496
Ivana Pulvirenti Italy 7 279 1.0× 74 0.9× 172 2.3× 55 0.9× 55 0.9× 7 527
Lynn Kohlmeier United States 11 187 0.7× 89 1.0× 181 2.4× 178 2.8× 77 1.3× 13 703
Taichi Kitaoka Japan 16 273 1.0× 88 1.0× 87 1.2× 113 1.8× 28 0.5× 49 798
Anastasia Dede Greece 8 158 0.6× 45 0.5× 127 1.7× 31 0.5× 80 1.3× 8 493
Chris von Ruhland United Kingdom 10 270 1.0× 55 0.6× 30 0.4× 104 1.6× 66 1.1× 14 605
Kanshi Minamitani Japan 15 188 0.7× 59 0.7× 45 0.6× 50 0.8× 34 0.6× 42 678
Midori Ishii Japan 15 136 0.5× 35 0.4× 144 1.9× 83 1.3× 26 0.4× 41 518
Tomohiro Udagawa Japan 9 198 0.7× 84 1.0× 25 0.3× 184 2.9× 124 2.1× 25 516
Alexander A. Kremzer Ukraine 17 381 1.4× 41 0.5× 81 1.1× 51 0.8× 32 0.5× 45 625
Adalbert Raimann Austria 13 98 0.4× 42 0.5× 98 1.3× 209 3.3× 18 0.3× 51 405

Countries citing papers authored by Seth Arum

Since Specialization
Citations

This map shows the geographic impact of Seth Arum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Arum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Arum more than expected).

Fields of papers citing papers by Seth Arum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth Arum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Arum. The network helps show where Seth Arum may publish in the future.

Co-authorship network of co-authors of Seth Arum

This figure shows the co-authorship network connecting the top 25 collaborators of Seth Arum. A scholar is included among the top collaborators of Seth Arum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth Arum. Seth Arum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badri, Prajakta, Bahru Habtemariam, Valerie A. Clausen, et al.. (2023). Pharmacokinetics and Pharmacodynamics of Patisiran in Patients with hATTR Amyloidosis and with Polyneuropathy After Liver Transplantation. Clinical Pharmacokinetics. 62(10). 1509–1522. 4 indexed citations
2.
Kale, Parag, Matthew J. Maurer, Marianna Fontana, et al.. (2023). Exploratory Analyses From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Attr Amyloidosis With Cardiomyopathy. Journal of Cardiac Failure. 29(4). 552–552. 2 indexed citations
3.
González‐Duarte, Alejandra, David Adams, Ivailo Tournev, et al.. (2022). HELIOS-A: RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY. Journal of the American College of Cardiology. 79(9). 302–302. 4 indexed citations
4.
Schmidt, Hartmut, Jonas Wixner, Violaine Planté‐Bordeneuve, et al.. (2022). Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation. American Journal of Transplantation. 22(6). 1646–1657. 35 indexed citations
5.
Adams, David, Ivailo Tournev, Mark Taylor, et al.. (2022). HELIOS-A: Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy (S8.003). Neurology. 98(18_supplement). 3 indexed citations
6.
Adams, David, Ivailo Tournev, Mark Taylor, et al.. (2022). Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial. Amyloid. 30(1). 18–26. 218 indexed citations breakdown →
7.
Pavía, Pablo García, Julian D. Gillmore, Parag Kale, et al.. (2022). HELIOS-A: 18-month exploratory cardiac results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis. Archives of Cardiovascular Diseases Supplements. 15(1). 31–32. 5 indexed citations
8.
Mussinelli, Roberta, Pablo García‐Pavía, Julian D. Gillmore, et al.. (2022). 77 HELIOS-A: 18-MONTH EXPLORATORY CARDIAC RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS. European Heart Journal Supplements. 24(Supplement_K). 5 indexed citations
9.
10.
Coelho, Teresa, Julian D. Gillmore, David Adams, et al.. (2021). Open-label Study of Patisiran in Patients with hATTR Amyloidosis Post-Orthotopic Liver Transplant (2144). Neurology. 96(15_supplement). 1 indexed citations
11.
Tournev, Ivailo, Mark Taylor, Teresa Coelho, et al.. (2021). HELIOS-A: 9-month results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. Journal of the Neurological Sciences. 429. 117767–117767. 4 indexed citations
12.
Makarov, Sergey N., et al.. (2020). Concept of a Radiofrequency Device for Osteopenia/Osteoporosis Screening. Scientific Reports. 10(1). 3540–3540. 21 indexed citations
13.
Gillmore, Julian D., John L. Berk, Angela Dispenzieri, et al.. (2020). Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. European Heart Journal. 41(Supplement_2). 1 indexed citations
14.
Arum, Seth, et al.. (2016). Management of adynamic bone disease in chronic kidney disease: A brief review. Journal of Clinical & Translational Endocrinology. 5. 32–35. 21 indexed citations
15.
Gilbert, Christopher R., Seth Arum, & Cecilia M. Smith. (2009). Vitamin D Deficiency and Chronic Lung Disease. Canadian Respiratory Journal. 16(3). 75–80. 74 indexed citations
16.
Arum, Seth. (2008). New developments surrounding the safety of bisphosphonates. Current Opinion in Endocrinology Diabetes and Obesity. 15(6). 508–513. 8 indexed citations
17.
Arum, Seth, Mary Cross, B Magnani, et al.. (2006). 123I Thyroid Uptake and Thyroid Size at 24, 48, and 72 Hours after the Administration of Recombinant Human Thyroid-Stimulating Hormone to Normal Volunteers. The Journal of Clinical Endocrinology & Metabolism. 91(2). 506–510. 30 indexed citations
18.
Morse, Leslie R., et al.. (2006). Vitamin D Deficiency and Osteoporosis in Rehabilitation Inpatients. Archives of Physical Medicine and Rehabilitation. 87(7). 904–908. 31 indexed citations
19.
Arum, Seth, Patricia L. M. Dahia, Katherine A. Schneider, & Lewis E. Braverman. (2005). A <I>RET </I>Mutation with Decreased Penetrance in the Family of a Patient with a. Endocrine. 28(2). 193–198. 7 indexed citations
20.
Morse, Leslie R., et al.. (2005). Poster 88. Archives of Physical Medicine and Rehabilitation. 86(9). e21–e21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana Pulvirenti Breakdown of academic impact, for papers by Lynn Kohlmeier Breakdown of academic impact, for papers by Taichi Kitaoka Breakdown of academic impact, for papers by Anastasia Dede Breakdown of academic impact, for papers by Chris von Ruhland Breakdown of academic impact, for papers by Kanshi Minamitani Breakdown of academic impact, for papers by Midori Ishii Breakdown of academic impact, for papers by Tomohiro Udagawa Breakdown of academic impact, for papers by Alexander A. Kremzer Breakdown of academic impact, for papers by Adalbert Raimann
Rankless by CCL
2026